Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
5 participants
INTERVENTIONAL
2005-06-30
2006-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Thalamic Deep Brain Stimulation for Tourette Syndrome
NCT03958617
Tourette Syndrome Deep Brain Stimulation
NCT02056873
Repetitive Transcranial Magnetic Stimulation to Reduce Tics
NCT01258790
tDCS in Tourette (TIC-TDCS)
NCT03401996
Transcranial Magnetic Stimulation for Children With Tourette's Syndrome
NCT02356003
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Thalamic deep brain stimulation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of Tourette Syndrome by DSM-IV
* Tic frequency at least one per minute at screening
* prior failure of at least two dopamine receptor or presynaptic blockers
* negative impact on quality of life
Exclusion Criteria
* significant dementia
* severe head trauma preceding onset of tics
* use of dopamine receptor blockers prior to recognition of tics
* prior implanted electrical device
* electroconvulsive therapy (ECT) within 24 months
* suicide attempt within 12 months
* significant sociopathic personality
* current or planned pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic
INDUSTRY
University Hospitals Cleveland Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert J Maciunas, MD MPH FACS
Role: PRINCIPAL_INVESTIGATOR
University Hospitals Cleveland Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospitals of Cleveland
Cleveland, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UHC DBS TS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.